baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

INCYTE DL-,001/ US45337C1027 /

5/24/2024 9:30:22 AM	Chg. -0.480	Volume	Bid3:27:01 PM	Ask3:27:01 PM	Market Capitalization	Dividend Y.	P/E Ratio
53.020EUR	-0.90%	1 Turnover: 53.020	52.880Bid Size: 190	53.120Ask Size: 189	11.93 bill.EUR	-	-

GlobeNewswire 5/9 MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...

GlobeNewswire 5/8 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 4/30 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer

GlobeNewswire 4/2 HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...

GlobeNewswire 4/1 CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...

GlobeNewswire 2/28 Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...

GlobeNewswire 1/9 Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

TeleTrader 12/12/2023 Wall Street closes higher after inflation report

GlobeNewswire 12/9/2023 CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program

GlobeNewswire 11/16/2023 CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...

GlobeNewswire 11/2/2023 Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update

GlobeNewswire 10/23/2023 Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...

GlobeNewswire 10/12/2023 Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032

GlobeNewswire 9/27/2023 Arcutis Appoints L. Todd Edwards as Chief Commercial Officer

TeleTrader 9/18/2023 Wall Street opens mostly lower, Fed anticipation builds up

GlobeNewswire 8/28/2023 Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer

TeleTrader 2/7/2023 Wall Street back to losses, Dow slides 200 points

TeleTrader 2/7/2023 US markets lower amid economic data, Fed's Powell

GlobeNewswire 3/23/2022 RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation An...

GlobeNewswire 3/14/2022 STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations

GlobeNewswire 3/1/2022 Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus R...

GlobeNewswire 2/28/2022 Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Up...

GlobeNewswire 2/24/2022 MacroGenics Provides Update on Corporate Progress and 2021 Financial Results

GlobeNewswire 1/25/2022 Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145

GlobeNewswire 1/10/2022 Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agre...

INCYTE DL-,001/ US45337C1027 /

If you wish to receive reply to your feedback, please provide your email address.